Possible mechanisms of paclitaxel-induced apoptosis

Biochemical Pharmacology

Volumn 57, Issue 11, 1999, Pages 1215-1221

  Fan, Weimin ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; bcl 2; Microtubule; Mitotic arrest; Paclitaxel

Indexed keywords

GLUCOCORTICOID; PACLITAXEL; PROTEIN BCL 2;

APOPTOSIS; CELL CYCLE G2 PHASE; DRUG MECHANISM; GENE EXPRESSION; HUMAN; MICROTUBULE; MITOSIS INHIBITION; PRIORITY JOURNAL; REVIEW;

EID: 0033151262     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00006-4     Document Type: Note

References (57)

1. Wani MC, Taylor HL, Wall ME, Coggon P and McPhail AT, Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
2. Rowinsky EK, Cazenave LA and Donehower RC, Taxol: A novel investigational antimicrotubule agent. J Natl Inst Cancer 82: 1247-1259, 1990.
3. Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB and Paietta E, Phase I clinical and pharmacokinetic study of taxol. Cancer Res 47: 2486-2493, 1987.
4. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK and Hortobagyi GN, Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797-1805, 1991.
5. Runowicz CD, Fields AL and Goldberg GL, Promising new therapies in the treatment of advanced ovarian cancer. Cancer 76 (Suppl 10): 2028-2033, 1995.
6. Schiff PB, Fant J and Horwitz SB, Promotion of microtubule assembly in vitro by paclitaxel. Nature 277: 665-667, 1979.
7. Wilson L, Bamburg JR, Mizel SB, Grisham LM and Creswell KM, Interaction of drugs with microtubule proteins. Fedn Proc 33: 158-166, 1974.
8. Manfredi JJ and Horwitz SB, Paclitaxel: An antimitotic agent with a new mechanism of action Pharmacol Ther 25: 83-125, 1984.
9. Turner PF and Margolis RL, Taxol-induced bundling of brain-derived microtubules. J Cell Biol 99: 940-946, 1984.
10. Fuchs DA and Johnson RK, Cytologic evidence that paclitaxel, an antineoplastic agent from Taxus brevifoliaz, acts as a mitotic spindle poison. Cancer Treat Rep 62: 1219-1222, 1978.
11. Bhalla K, Ibrado AM, Tourhina E, Tang C, Mahonery ME and Huang Y, Taxol-induced internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7: 563-568, 1993.
12. Fan W, Everett ET, Tang C, Cooper T, Fang Q, Bhalla K and Norris JS, Glucocorticoid-mediated inhibition of paclitaxel-induced apoptosis in leiomyosarcoma cells. Cell Pharmacol 1: 205-212, 1994.
13. Cheng L, Zheng S, Raghunathan K, Priest DG, Willingham MC, Norris JS and Fan W, Characterizations of paclitaxel-induced apoptosis and altered gene expression in human breast cancer cells. Cell Pharmacol 2: 249-257, 1995.
14. Liu Y, Bhalla K, Hill C and Priest DG, Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line. Biochem Pharmarcol 48: 1265-1272, 1995.
15. Areds MJ, Morris RG and Wyllie AH, Apoptosis: The role of the endonuclease. Am J Pathol 136: 593-608, 1990.
16. Waring P, Kos FJ and Mullbacher A, Apoptosis or programmed cell death. Med Res Rev 11: 219-236, 1991.
17. Fan W, Cheng LR, Norris JS and Willingham MC, Glucocorticoids selectively inhibit paclitaxel-induced apoptosis in a human breast cancer cell line. Cell Pharmacol 3: 435-440, 1996.
18. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H and Wilson L, Mitotic block induced in hela cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56: 816-825, 1996.
19. 2/M block. Proc Am Assoc Cancer Res 38: 530, 1997.
20. Lieu C-H, Chang Y-N and Lai Y-K, Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells. Biochem Pharmacol 53: 1587-1596, 1997.
21. Parekh HK and Simpkin H, Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system? Biochem Pharmacol 51: 301-311, 1996.
22. Jordan MA, Toso RJ, Thrower D and Wilson L, Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90: 9552-9556, 1993.
23. Fan W, Cooper T and Norris JS, Characterization of selective glucocorticoid dependent responses in a glucocorticoid-resistant smooth muscle cell line. J Cell Physiol 156: 88-95, 1993.
24. Fan W, Schandl CA, Cheng JS and Willingham MC, Glucocorticoids modulate paclitaxel cytotoxicity in human solid tumor cells. Cell Pharmacol 3: 343-348, 1996.
25. Kingston DG, The chemistry of taxol. Pharmacol 52: 1-34, 1991.
26. Parness J, Kingston DGI, Powell RG, Harracksingh C and Horwitz SB, Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanes. Biochem Biophys Res Commun 105: 1082-1089, 1982.
27. Horwitz SB, Mechanism of action of taxol. Trends Pharmacol Sci 13: 134-136, 1992.
28. Lataste H, Senilh V, Wright M, Guénard D and Potier P, Relationships between the structures of taxol and baccatine III derivatives and their in vitro action on the disassembly of mammalian brain and Physarum amoebal microtubules. Proc Natl Acad Sci USA 81: 4090-4094, 1984.
29. Fan W, Miller MC, Cheng RL and Willingham MC, Taxol-induced apoptosis may occur via a signaling pathway independent of microtubule bundling and cell cycle arrest. Micro Microanal 4 (2 Suppl): 1042-1043, 1998.
30. Parekh H and Simpkins H, The transport and binding of taxol. Gen Pharmacol 29: 167-172, 1997.
31. Dustin O, Microtubules. Sci Am 243: 66-76, 1980.
32. Teng MH, Bartholomew JC and Bissei MJ, Synergism between antimicrotubule agents and growth stimulation in enhancement to cell cycle traverse. Nature 368: 739-741, 1977.
33. MiLas L, Hunter NR, Kurdoglu B, Mason KA, Meyn RE, Stephens LC and Peters LJ, Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol 35: 297-303, 1995.
34. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW and Galloway DA, Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nat Med 2: 72-79, 1996.
35. Johnson KR, Wang L, Miller MC III, Willingham MC and Fan W, 5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells. Clin Cancer Res 3: 1739-1745, 1997.
36. Rostum YM, Pyrimidine antagonists in cancer therapy. In: Encyclopedia of Cancer (Ed. Bertino JR), pp. 1327-1336. Academic Press, New York, 1996.
37. Crossin KL and Carney DH, Microtubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor. Cell 27: 341-350, 1981.
38. cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ 5: 1041-1050, 1994.
39. WAF1 and p53 requires c-raf-1. Cancer Res 55: 4623-4626, 1995.
40. Moos PJ and Fitzpatrick FA, Taxane-mediated gene induction is independent of microtubule stabilization: Induction of transcriptional regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci USA 95: 3896-3901, 1998.
41. Saunders De, Lawrence WD, Christensen C, Wappler NL, Ruan H and Deppe G, Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells. Int J Cancer 70: 214-220, 1997.
42. Haldar S, Jena N and Croce CM, Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511, 1995.
43. Haldar S, Chintapalli J and Croce CM, Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253-1255, 1996.
44. Strobel T, Swanson L, Korsmeyer S and Cannistra SA, BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci USA 90: 14094-14099, 1996.
45. l overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res 57: 1109-1115, 1997.
46. Ding AH, Porteu F, Sanchez E and Nathan CF, Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248: 370-372, 1990.
47. Lee LF, Schuerer-Maly CC, Lofquist AK, van Haaften-Day C, Ting JPY, White CM, Martin BK and Haskill JS, Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res 56: 1303-1308, 1996.
48. Manthey CL, Breandes ME, Perera PY and Vogel SN, Paclitaxel increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol 149: 2459-2465, 1992.
49. cdc2 kinase activation and apoptosis inhibited by 12-o-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. Cell Growth Differ 9: 23-29, 1998.
50. Reed JC, Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 7: 541-546, 1995.
51. Boise LH, Gottscalk AR, Quintan J and Thompson CB, Bcl-2 and bcl-2-related proteins in apoptosis regulation. Curr Top Microbiol Immunol 300: 107-121, 1993.
52. Blagosklonny MV, Schulte T, Nguyen P, Trepel J and Neckers LM, Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 56: 1851-1854, 1996.
53. Fang G, Chang BS, Kim CN, Perkins C, Thompson CB and Bhalla KN, "loop" domain is necessary for taxol-induced mobility shift and phosphorylation of bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res 58: 3202-3208, 1998.
54. Baeuerle PA and Henkel T, Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179, 1994.
55. Lanni JS, Lowe SW, Licitra EJ, Liu JO and Jack T, P53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sci USA 94: 9679-9683, 1997.
56. Millenbaugh NJ, Gan Y and Au JLS, Cytostatic and apoptotic effects of paclitaxel in human ovarian tumors. Pharm Res 15: 122-127, 1998.
57. Milross CG, Mason KA, Hunter NR, Chung W-K, Peters LJ and Milas L, Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 88: 1308-1314, 1996.